NCT06243809View on ClinicalTrials.gov

The Bioequivalence Study of Linagliptin 5 mg Film-coated Tablet in Healthy Thai Volunteers

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 24, 2024

Primary Completion Date

May 10, 2024

Study Completion Date

July 2, 2024

Conditions
Healthy Volunteer
Interventions
DRUG

Linagliptin 5 mg Oral Tablet

Linagliptin 5 mg Oral Tablet

DRUG

Trajenta 5 MG Oral Tablet

Linagliptin 5 mg Oral Tablet (Trajenta )

Sponsors
All Listed Sponsors
lead

International Bio service

NETWORK